Orientations réglementaires
CAMD MDR/IVDR Transition Subgroup: FAQ – MDR Transitional provisions
Publié 1 janv. 2018
Référence
CAMD FAQ
Source
MDCG
Thème
Other guidance documents
Publié
1 janv. 2018
Langues
EN
© European Union — European Commission, DG SANTE. Reuse under CC BY 4.0.
Update on the guidelines on the benefit-risk assessment of the presence of phthalates in certain medical devicescovering phthalates which are carcinogenic, mutagenic, toxic to reproduction (CMR) or have endocrine-disrupting (ED) properties
Publié 1 juin 2024
Overview of language requirements for manufacturers of medical devices for the information and instructions that accompany a device in a specific country
Publié 1 janv. 2024
Questions & Answers for applicants, marketing authorisation holders of medicinal products and notified bodies with respect to the implementation of the Medical Devices and In Vitro Diagnostic Medical Devices Regulations ((EU) 2017/745 and (EU) 2017/746)
Publié 1 juin 2021
Guidance on Classification Rules for in vitro Diagnostic Medical Devices under Regulation (EU) 2017/746
Publié 1 sept. 2026